The pharmaceutical company submissions to Health Canada is delaying the access to new prescription drugs rather than delay by a longer approval-processing time, suggests an analysis published in CMAJ (Canadian Medical Association Journal).
The submission of new drugs to Health Canada is substantially delayed compared with submissions in the United States and the European Union.
Improvement Needed for Postmarketing Studies of Prescription Drugs
Because rare but potentially serious adverse events of prescription drugs are often discovered only after market approval, observational postmarketing studies constitute an important part of the U.S. drug safety system.
Advertisement
"New drugs reached the market much later in Canada than in the US and the EU because of long delays before their submission to Health Canada," write Ali Shajarizadeh and Aidan Hollis, Department of Economics, University of Calgary, Calgary, Alberta. "For drugs that were ultimately approved in Canada and in at least one of the other jurisdictions, the mean delay from first submission in either foreign jurisdiction to submission in Canada was 540 days."
The authors determined that the capacity of pharmaceutical companies to navigate the regulatory process in less-profitable countries such as Canada — smaller companies may lack resources and expertise — and the desire to obtain approval of first-in-class drugs with higher potential sales are the main reasons for timing of submissions.
![Millions of People in US Use Prescription Drugs to Sleep]( "Millions of People in US Use Prescription Drugs to Sleep")
More than nine million people in the United States use prescription drugs to sleep according to a new study.
"We found that corporate capacity and priority status of new drugs are important determinants of submission delays," write the authors.
"We believe that the harmonization of the regulatory processes of the FDA and Health Canada may accelerate drug submissions in Canada," conclude the authors, although they note that the situation can vary for each drug.
Source: Eurekalert
Millions of People in US Use Prescription Drugs to Sleep
More than nine million people in the United States use prescription drugs to sleep according to a new study.
Advertisement
"We found that corporate capacity and priority status of new drugs are important determinants of submission delays," write the authors.
"We believe that the harmonization of the regulatory processes of the FDA and Health Canada may accelerate drug submissions in Canada," conclude the authors, although they note that the situation can vary for each drug.
Source: Eurekalert
One in Four Teens Admit Abusing Prescription Drugs at Least Once in Their Lives
A nationally projectable survey reveals the rising trend of drug abuse among teenagers with the results showing an increase of 33 percent.
Advertisement
 7 in 10 People Take Prescription Drugs, Say ResearchersA recent study states that almost 70 percent of US citizens take at least one prescription drug, and more than 50 percent take two. | Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.